Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1993 Sep;77(9):579–583. doi: 10.1136/bjo.77.9.579

Cataract and myotonic dystrophy: the role of molecular diagnosis.

W Reardon 1, J C MacMillan 1, J Myring 1, H G Harley 1, S A Rundle 1, L Beck 1, P S Harper 1, D J Shaw 1
PMCID: PMC513956  PMID: 8218057

Abstract

Myotonic dystrophy (dystrophia myotonica), the commonest and most variable of the muscular dystrophies of adult life, has long been known to be associated with cataract, while slit-lamp examination for specific lens opacities has been one of the principal methods of presymptomatic detection of gene carriers. The recent discovery that the myotonic dystrophy mutation is an unstable DNA sequence, composed of varying numbers of CTG triplet repeats, now allows a specific molecular test for this disorder, as well as explaining the phenomenon of anticipation. A series of case reports is presented to illustrate the important practical applications of this development in relation to ophthalmic aspects of the disorder. Reassessment of the specificity of the ophthalmic changes may be required and it will be important for molecular analysis to be used alongside ophthalmic studies, when determining whether family members carry the mutation for myotonic dystrophy.

Full text

PDF
579

Images in this article

580Image
on p.580
581Image
on p.581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashizawa T., Hejtmancik J. F., Liu J., Perryman M. B., Epstein H. F., Koch D. D. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet. 1992 Jan 1;42(1):55–60. doi: 10.1002/ajmg.1320420113. [DOI] [PubMed] [Google Scholar]
  2. Aslanidis C., Jansen G., Amemiya C., Shutler G., Mahadevan M., Tsilfidis C., Chen C., Alleman J., Wormskamp N. G., Vooijs M. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 1992 Feb 6;355(6360):548–551. doi: 10.1038/355548a0. [DOI] [PubMed] [Google Scholar]
  3. Brook J. D., McCurrach M. E., Harley H. G., Buckler A. J., Church D., Aburatani H., Hunter K., Stanton V. P., Thirion J. P., Hudson T. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992 Feb 21;68(4):799–808. doi: 10.1016/0092-8674(92)90154-5. [DOI] [PubMed] [Google Scholar]
  4. Brunner H. G., Smeets H. J., Nillesen W., van Oost B. A., van den Biezenbos J. B., Joosten E. M., Pinckers A. J., Hamel B. C., Theeuwes A. G., Wieringa B. Myotonic dystrophy. Predictive value of normal results on clinical examination. Brain. 1991 Oct;114(Pt 5):2303–2311. doi: 10.1093/brain/114.5.2303. [DOI] [PubMed] [Google Scholar]
  5. Bundey S., Carter C. O., Soothill J. F. Early recognition of heterozygotes for the gene for dystrophia myotonica. J Neurol Neurosurg Psychiatry. 1970 Jun;33(3):279–293. doi: 10.1136/jnnp.33.3.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992 Feb 6;355(6360):547–548. doi: 10.1038/355547a0. [DOI] [PubMed] [Google Scholar]
  7. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 1992 Feb 6;355(6360):547–548. doi: 10.1038/355547a0. [DOI] [PubMed] [Google Scholar]
  8. Harper P. S., Harley H. G., Reardon W., Shaw D. J. Anticipation in myotonic dystrophy: new light on an old problem. Am J Hum Genet. 1992 Jul;51(1):10–16. [PMC free article] [PubMed] [Google Scholar]
  9. Harper P. S. Pre-symptomatic detection and genetic counselling in myotonic dystrophy. Clin Genet. 1973;4(2):134–140. doi: 10.1111/j.1399-0004.1973.tb01134.x. [DOI] [PubMed] [Google Scholar]
  10. Meredith A. L., Huson S. M., Lunt P. W., Sarfarazi M., Harley H. G., Brook J. D., Shaw D. J., Harper P. S. Application of a closely linked polymorphism of restriction fragment length to counselling and prenatal testing in families with myotonic dystrophy. Br Med J (Clin Res Ed) 1986 Nov 22;293(6558):1353–1356. doi: 10.1136/bmj.293.6558.1353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Norman A. M., Floyd J. L., Meredith A. L., Harper P. S. Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers. J Med Genet. 1989 Dec;26(12):750–754. doi: 10.1136/jmg.26.12.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. O'Hoy K. L., Tsilfidis C., Mahadevan M. S., Neville C. E., Barceló J., Hunter A. G., Korneluk R. G. Reduction in size of the myotonic dystrophy trinucleotide repeat mutation during transmission. Science. 1993 Feb 5;259(5096):809–812. doi: 10.1126/science.8094260. [DOI] [PubMed] [Google Scholar]
  13. Reardon W., Floyd J. L., Myring J., Lazarou L. P., Meredith A. L., Harper P. S. Five years experience of predictive testing for myotonic dystrophy using linked DNA markers. Am J Med Genet. 1992 Aug 1;43(6):1006–1011. doi: 10.1002/ajmg.1320430618. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES